Infectious Disease Doctors in Springfield, OR Accepting Medicare

4 Infectious Disease doctors found. Showing 1 - 4

Dr. Jason Daniel Cronin, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3377 Riverbend Dr, Springfield, OR 97477 Phone: 541-222-6345    Fax: 541-222-6353

Brenda Michelle Ormesher, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3377 Riverbend Dr, Springfield, OR 97477 Phone: 541-222-6345

Dr. Tara Rani Perti, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 960 N 16th St Ste 108, Springfield, OR 97477 Phone: 541-345-2205

Kialing Perez, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3333 Riverbend Dr, Hyperbaric Center, Springfield, OR 97477 Phone: 541-222-4500    Fax: 541-222-1786

News Archive

Portola Pharmaceuticals starts phase 2 trial of P2Y12 ADP receptor antagonist in non-urgent percutaneous coronary intervention

Portola Pharmaceuticals has announced that it has initiated patient enrollment in INNOVATE-PCI, a large Phase II clinical trial of PRT060128, the Company's novel P2Y12 ADP receptor antagonist, in patients undergoing non-urgent percutaneous coronary intervention (PCI).

Placental-derived stem cell therapy shows promise to heal intestinal disease in premature babies

An intestinal bowel disease that affects up to 10 percent of premature infants at a very vulnerable and developmentally crucial time can lead to serious infection and death.

New insights into how the brain's internal states influence decision-making

Biomedical Engineering's Matthew Smith and Byron Yu, along with former Ph.D. student Ben Cowley (School of Computer Science '18), have studied the neural basis through which internal states in the brain affect decision-making over an extended period of time.

Gemcitabine drug improves survival rates in patients with pancreatic cancer

Among patients with pancreatic cancer who had surgery for removal of the cancer, treatment with the drug gemcitabine for 6 months resulted in increased overall survival as well as disease-free survival, compared with observation alone, according to a study in the October 9 issue of JAMA.

Read more Medical News

› Verified 3 days ago